EP3139948
TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21
:
EP einkaleyfi: Þýðing ekki lögð inn:
5.5.2015:
4.3.2020:
15720982.6
:
4.5.2035
:
TREATMENT OF DIABETES TYPE 1 USING GLP-1 AND ANTI-IL-21
5.5.2015
4.3.2020
:
Novo Nordisk A/S:
Novo Allé, 2880 Bagsværd, DK
:
COPPIETERS, Ken:
2880 Bagsværd, DK
:
VON HERRATH, Matthias:
Seattle, Washington 98109, US
:
BOURSALIAN, Tamar:
Seattle, Washington 98109, US
:
201461989841 P:
7.5.2014:
US
:
14169596:
23.5.2014:
EP
:
14189732:
21.10.2014:
EP
:
EP2015059811:
5.5.2015
:
A61K 38/26, A61K 39/395, A61P 3/10, C07K 16/24, A61K 39/00